MYCN and neuroblastoma: The p110β isoform has also been implicated in various malignancies [18,19], but we could not detect any difference between stage 1–2 and stage 4 neuroblastoma p110β protein levels (Figure 1B), although slightly higher levels were detected in MYCN amplified tumors (Additional file 1).